Company Filing History:
2 out of 810 
1 out of 832,843 Years Active: 2009-2014
Title: Chana Weiss: Innovator in Angiogenesis Research
Introduction
Chana Weiss is a notable inventor based in Giv′at-Shmuel, Israel. She has made significant contributions to the field of angiogenesis research, holding a total of 3 patents. Her work focuses on developing innovative methods and compositions that can potentially treat angiogenesis-related pathologies.
Latest Patents
Among her latest patents is a groundbreaking invention titled "Compositions and methods for inducing angiogenesis." This patent describes an isolated peptide comprising an amino acid sequence HWRR, as set forth by SEQ ID NO:5. The peptide consists of 4 or 5 amino acids and is designed to be used in methods for treating conditions related to angiogenesis. The invention also includes pharmaceutical compositions that incorporate this peptide, showcasing her commitment to advancing medical treatments.
Career Highlights
Chana Weiss has worked with Ramot at Tel Aviv University Ltd., where she has been able to apply her research in a collaborative environment. Her innovative approach has led to the development of valuable intellectual property that contributes to the scientific community.
Collaborations
Chana has collaborated with notable individuals in her field, including Britta Hardy and Alexander Battler. These partnerships have likely enhanced her research and contributed to her success as an inventor.
Conclusion
Chana Weiss is a prominent figure in the field of angiogenesis research, with a focus on developing innovative solutions for related medical conditions. Her contributions through her patents and collaborations highlight her dedication to advancing scientific knowledge and improving healthcare outcomes.